Navigation Links
Hepatitis B Foundation Testifies Before Congressional Appropriation Committee and Urges More Federal Funding for Hepatitis B

DOYLESTOWN, Pa., March 20 /PRNewswire-USNewswire/ -- Hepatitis B Foundation President Dr. Timothy Block testified about the public health challenge of chronic hepatitis B before the Congressional Appropriations Subcommittee on Labor, Health and Human Services on March 13 in Washington, DC, at the request of Honorable David Obey, chairman, Committee on Appropriations. Dr. Block spoke about the urgent need to strengthen and increase funding for hepatitis B programs at the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH).

"The recent crisis in a Nevada clinic, where 40,000 people were placed at risk for infection with hepatitis B and C, is a problem that the CDC thinks might just be the tip of the iceberg," said Dr. Block. "This incident highlights critical deficiencies in our public health and research programs, and if we don't act with urgency, more and more people will suffer."

The Foundation believes that a well-equipped CDC is our best hope to manage the public health problem of hepatitis B. Two million chronically infected Americans are depending upon the NIH to search for new interventions to treat hepatitis B and liver cancer, a fatal outcome of chronic hepatitis B and the fastest growing cancer in the U.S. today. Both the CDC and NIH have performed admirably with the limited resources they are provided; however, much more is needed to achieve effective, lasting solutions.

Dr. Block concluded his testimony by urging the appropriations subcommittee to restore in FY 2009 the overall CDC budget to $7.4 billion with a $50 million increase for the Division of Viral Hepatitis, and to provide a 6.7% increase for the NIH bringing the total to $31.2 billion, including a $40 million annual increase for hepatitis B research.

Chairman David Obey was sympathetic and commented on the importance of restoring cuts to the NIH and CDC budget to address important health issues.

About the Hepatitis B Foundation

The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through research, education and patient advocacy. For more information, visit or call (215) 489-4900.

Contact: Leah Rice

(215) 340-0480 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Dr. Timothy Block Joan Block

SOURCE Hepatitis B Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
2. Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
3. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
4. Conatus Pharmaceuticals Initiates a Phase 2 Clinical Trial for the Treatment of Hepatitis
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
7. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
8. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
9. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
10. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
11. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
Post Your Comments:
(Date:10/13/2015)... , October 13, 2015 ... in the development of innovative peptide and gene-based immunotherapeutics ... disease, will be a featured presenting company at the ... the Wyndham Grand Hotel in Jupiter, Florida ... TapImmune, Inc. (TPIV), a clinical-stage immunotherapy company specializing ...
(Date:10/13/2015)... ... October 13, 2015 , ... SonaCare ... announced today that it received de novo clearance from the U.S. Food and ... the ablation of prostate tissue. Sonablate® is the first High Intensity Therapeutic Ultrasound ...
(Date:10/12/2015)... ... October 12, 2015 , ... Spirax Sarco, the leader ... of the CSM-C 600 compact clean steam generator . This unit is ... the requirements of HTM2031, HTM2010, and EN285 standards. The CMS-C 600 generator can ...
(Date:10/12/2015)... , 12 de octubre de 2015 El ... llegó a un récord en el congreso con su ... de la International Plasma Awareness Week (IPAW), que se ... está patrocinada por la Plasma Protein Therapeutics Association ... , Aumentar la concienciación mundial acerca ...
Breaking Biology Technology:
(Date:10/7/2015)... , October 7, 2015 ... company focused on the growing mobile commerce market and ... Stanley E. Washington , former long- term executive at ... Directors. --> NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ...
(Date:10/5/2015)... 5, 2015 ) ... NXT-ID, Inc. (NASDAQ: NXTD ), a biometric authentication ... --> ) releases the following ... NXTD ), a biometric authentication company focused on the ... Group ( ) releases the following ...
(Date:9/30/2015)... Sept. 30, 2015  With nearly 300,000 Americans living ... new SCIs estimated to reach 12,500 annually, the role ... Resource Services for Independent Living (SCRS-IL) is increasingly ... California opening doors to independence for ... and services, notably assistive technology services and education. ...
Breaking Biology News(10 mins):